Dr Andrew Naylor promoted to Chief Operating Officer
Having led the R+D function at 4D Medicine since joining the management team in September 2020, Dr Andrew Naylor has been promoted to the new role of Chief Operating Officer for the 4D Group.
With this exciting new challenge, Andy will build on his role as operational lead at the company’s facilities in MediCity, as we move towards commercialisation on an international scale.
Andy brings over 20 years of experience in polymer technology transfer and a strong track record of taking new technologies from spin-out to market.
4D CEO Phil Smith said “Andy has been key to 4D’s operational success over the last four years and he fully deserves this promotion. I look forward to continuing to work closely with him, as together, we take the business onwards and upwards!”.
